Impact of rotavirus vaccination: The importance of monitoring strains

Future Microbiology

Volumn 4, Issue 10, 2009, Pages 1231-1234

  Gentsch, Jon R ^a   Parashar, Umesh D ^a   Glass, Roger I ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTATEG; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CROSS REACTION; DRUG EFFICACY; EDITORIAL; GENETIC REASSORTMENT; HUMAN; MASS IMMUNIZATION; PRIORITY JOURNAL; ROTAVIRUS; SEROTYPE; VACCINATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; GENETIC VARIATION; GENOTYPE; HUMANS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SENTINEL SURVEILLANCE;

ROTAVIRUS;

EID: 74749087711     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.105     Document Type: Editorial

References (28)

1. Matthijnssens J, Bilcke J, Ciarlet M et al.: Rotavirus disease and vaccination: impact on genotype diversity Future Microbiol. 4(10), 1303-1316 (2009).
2. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. MMWR Morb. Mortal. Wkly Rep. 57(25), 697-700 (2008).
3. Tate JE, Panozzo CA, Payne DC et al.: Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 124(2), 465-471 (2009).
4. Matthijnssens J, Rahman M, Ciarlet M, Ranst MV: Emerging human rotavirus genotypes. In: Viruses in the Environment. Palombo EA, Kirkwood CD (Eds). Research Signpost, Trivandrum, India 171-219 (2008).
5. Gentsch JR, Laird AR, Bielfelt B et al.: Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 192(Suppl. 1), S146-S159 (2005).
6. Santos N, Hoshino Y: Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15, 29-56 (2005).
7. Estes MK, Kapikian AZ: Rotaviruses. In: Fields Virology (5th Edition). Knipe DM, Howley PM, Griffin DE et al. (Eds). Lippincott Williams & Wilkins, PA, USA 1917-1974 (2007).
8. Linhares AC, Velazquez FR, Perez-Schael I et al.: Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled Phase III study [see comment]. Lancet 371(9619), 1181-1189 (2008).
9. Vesikari T, Matson DO, Dennehy P et al.: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine [see comment]. N. Engl. J. Med. 354(1), 23-33 (2006).
10. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al.: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis [see comment]. N. Engl. J. Med. 354(1), 11-22 (2006).
11. Vesikari T, Karvonen A, Prymula R et al.: Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study [see comment]. Lancet 370(9601), 1757-1763 (2007).
12. Ball JM, Tian P, Zeng CQ-Y, Morris AP, Estes MK: Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272, 101-104 (1996).
13. Burns JW, Majid S-P, Krishnaney AA, Greenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272, 104-107 (1996).
14. Leite JP, Carvalho-Costa FA, Linhares AC: Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz 103(8), 745-753 (2008).
15. Bishop RF, Unicomb LE, Barnes GL: Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989. J. Clin. Microbiol. 29(5), 862-868 (1991).
16. Gurgel RQ, Correia JB, Cuevas LE: Effect of rotavirus vaccination on circulating virus strains [see comment]. Lancet 371(9609), 301-302 (2008).
17. Nakagomi T, Cuevas LE, Gurgel RG et al.: Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol. 153(3), 591-593 (2008).
18. Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD: Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis. 14(5), 863-865 (2008).
19. Gurgel R, Bohland A, Vieira S et al.: Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology (2009) (Epub ahead of print).
20. Kirkwood C, Boniface C, Barnes G, Bishop R: Rotavirus genotype distribution in Australian children - what has happened during the first 18 months after introduction of RotaTeqTM and RotarixTM. Presented at: Vaccines for Enteric Diseases Meeting. Malaga, Spain, 9-11 September 2009.
21. Lambert SB, Faux CE, Hall L et al.: Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med. J. Aust. 191(3), 157-160 (2009).
22. Ward KA, McIntyre PB, Kirkwood CD et al.: Rotavirus surveillance in Australia. Commun. Dis. Intell. 32(1), 82-87 (2008).
23. Payne DC, Staat MA, Edwards K et al.: Active population-based surveillance for severe rotavirus gastroenteritis in US children. Pediatrics 122(6), 1235-1243 (2008).
24. Hull J, Teel E, Kerin T et al.: Report of the U.S. rotavirus strain surveillance (1996-2008). Presented at: American Society for Microbiology Meeting. Vancouver, Canada, 11-15 July 2009 (Abstract P37-2).
25. Boom J, Tate J, Sahni L et al.: Effectiveness of pentavalent rotavirus vaccine in a large, urban U.S. population. Pediatrics (2009) (In Press).
26. Patel M, Pedreira C, De Oliveira LH et al.: Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua [see comment]. JAMA 301(21), 2243-2251 (2009).
27. Cunliffe N, Gondwe JS, Graham SM et al.: Rotavirus strain diversity in Blantyre, Malawi from 1997 to 1999. J. Clin. Microbiol. 39, 836-843 (2001).
28. Cunliffe N, Witte D, Ngwira B et al.: Efficacy and immunogenicity of human rotavirus vaccine RIX4414 in Malawian infants. Presented at: Vaccines for Enteric Diseases Meeting. Malaga, Spain, 9-11 September 2009.